Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,972,092
+$12,102,259 QoQ
Shares Held
1,671,648
+1.3% QoQ
Ownership
3.64%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#7
of 151 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $199,243,952 across 2 Drug Manufacturers - Specialty & Generic names. BIOA ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
15,827,186 | $158,271,860 | |
| 2 | BIOA |
BioAge Labs, Inc.
This page
|
1,671,648 | $40,972,092 |
All Filings in BIOA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,972,092 | 1,671,648 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,869,833 | 1,650,648 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $3,957,377 | 1,052,494 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,588,310 | 1,310,589 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $45,980,251 | 2,210,589 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||